NSE · KPL

Kwality Pharmaceuticals Limited

Sector: Healthcare · ISIN: INE552U01010

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#953

of 5,096 stocks

▲ 171W

Peak #944 · 27 Sep 2026

Kwality Pharmaceuticals Limited is a smallcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and generates a high return on equity. Ownership as of Jun 2026.

Market Cap

3,711.46 Cr

P/E Ratio

55.11

P/B Ratio

11.25

ROE

20.41%

ROCE

27.62%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	162.35 Cr	157.11 Cr	123.44 Cr	111.05 Cr
Net Profit	25.62 Cr	25.31 Cr	16.00 Cr	14.12 Cr
EPS	24.69	24.39	15.42	13.60
Operating Profit	36.65 Cr	34.56 Cr	25.66 Cr	21.29 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

54.86%

Public

45.14%

PUBLIC BREAKDOWN

FII

3.13%

DII

0.56%

MF (within DII)

0.00%

Individuals

38.49%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

₹0.05

Cr total

Schemes

Fund Houses

₹0.05 Cr

Total Exposure

Motilal Oswal Mutual Fund₹0.03 Cr (65.1%)

Bandhan Mutual Fund₹0.02 Cr (34.9%)

Scheme	Fund House	Value (Cr)	%

All MF holders by market value as of 01 Jul 2026.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs